Breaking News!
JANUMET results in greater blood sugar reductions in patients with type 2 diabetes compared to pioglitazone
yahoo-com
New data were presented at the American Diabetes Association 70th Annual Scientific Sessions from a study comparing JANUMET (sitagliptin/metformin) to pioglitazone. In this study, JANUMET resulted in significantly greater blood sugar reductions in patients with type 2 diabetes compared with pioglitazone....
Reproduced under the Fair Use exception of 17USC107
Related Stories
Responses //
0
Add Something
Post Your Response
Post Your Story












